In Memory of John Mordaunt

John Mordaunt was a tireless advocate of HIV infected drug users.
He was the first HIV+ drug user to be shown on national television in his
country, England. Mordaunt helped to found the British advocacy organization
for HIV infected drug users called Frontliners and was active with
the European Interest Group on Drug Policy, a European umbrella
organization for user groups. In spite of his illness Mordaunt accomplished
an incredible amount of work as a champion for the civil liber ties of
drug users. In 1990 upon learning of NAMA Mordaunt wrote to us with his
encouragement and how methadone had given him the chance to have a normal
life. The letter was published in a small newsletter that proceeded The
Ombudsman, called NAMA New s & Notes.

John Mordaunt devoted the last years of his life to making changes,
his energy and presence will be missed.

JW

Similar Posts

  • New Methadone Regulations in the U.S.

    Admin 05/07/2021

    Press Release July 22, 1999 National Alliance of Methadone Advocates NAMA 435 Second Avenue New York, NY 10010 Email: [email protected] NAMA applauds the hard work of SAMHSA, the ONDCP, NIDA and CSAT for the release of the New Accreditation Guidelines for Methadone and LAAM Treatment. We are aware that these agencies have made tremendous efforts…

  • Category: Lane Holden Award

    Admin 07/18/2022

    Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! May 1, 2022 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive Director of Man Alive and later served as Vice President…

  • COVID-19 Resources

    Admin 01/17/2022

    CORONAVIRUS Resources We’ve gathered some resources from around the nation to support organizations, employees, and individuals through the COVID-19 pandemic. Resources from the Substance Abuse & Mental Health Services Administration. Relevant resources from other federal agencies. STATE RESOURCES Relevant resources from state agencies arount the nation. OTHER AGENCIES Relevant resources from non-government agencies. SAMHSA’s COVID-19…

  • Archives

    Admin 07/05/2021

    2009 National Alliance of Methadone Advocates. NAMA Announces New Name. Press Release, April 26, 2009. 2004 National Alliance of Methadone Advocates. National Alliance of Methadone Advocates Calls on Advocates To Remind Policy Makers To Include Medication Assisted Treatment in Access to Recovery Grants. Press Release, June 14, 2004. Curley, B. Recovery Advocates Sharpen Their Skills. Join Together, June…

  • Buprenorphine treats opiate addiction in office; Two Sublingual Formulations Approved

    Admin 01/17/2023

    Mechcatie, Elizabeth. Family Practice News 32(22): 7. November 15, 2002 The approval of the partial opioid agonist buprenorphine for treating opiate dependence has paved the way for office-based treatment of opioid addiction and far greater access to treatment for hundreds of thousands of heroin addicts across the country. Two sublingual formulations have been approved: Buprenorphine…

  • DRAFT

    Admin 06/23/2022

    Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Draft approved for distribution July 2001 THE FEDERATION OF STATE MEDICAL BOARDS OF THE UNITED STATES, INC. Introduction On October 17, 2000, “The Children’s Health Act of 2000” (HR 4365) was signed into federal law. Section 3502 of that Act sets forth the “Drug…